Elena P.
- Country
- Spain
- Department
- Pediatric
Research Overview
Data & Insights
Has run more than one trial at 0 of 29 partner sites.
Specializations
Pediatric Oncology
The investigator specializes in treating young patients with advanced solid tumors and demonstrates particular expertise in studying targeted therapies for tumors with specific genetic alterations including ROS1 and NTRK1-3.
- Advanced Solid Tumors
- Genetic Mutation Analysis
- Targeted Therapy Development
Their research extends to evaluating novel therapeutic approaches for pediatric and young adult patients with complex oncological conditions.
Lymphoma Treatment
The investigator focuses on innovative treatment approaches for classical Hodgkin lymphoma and non-Hodgkin lymphoma in pediatric and young adult populations, with particular emphasis on refractory and recurrent cases.
- Combination Immunotherapy
- Relapsed/Refractory Lymphomas
- Age-Specific Treatment Protocols
Their work encompasses developing treatment strategies for patients up to 30 years of age, addressing specific challenges in this age group.
Drug Development
The investigator's expertise includes evaluating novel therapeutic combinations, particularly focusing on immunotherapy agents such as relatlimab and nivolumab, with emphasis on determining optimal dosing and safety profiles.
- Safety and Tolerability Studies
- Dose Optimization
- Pharmacokinetic Analysis
Their research includes comprehensive evaluation of drug combinations' safety profiles and therapeutic efficacy in young patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.